English
Français
Deutsch
العربية
Português
Español
简体中文

News Detail
Home / News / Company News / Goldsite COVID-19 SARS-CoV-2 Antigen Kit Approved by Malaysia MDA

Goldsite COVID-19 SARS-CoV-2 Antigen Kit Approved by Malaysia MDA

Publish Time: 2021-09-30     Origin: Site

Goldsite COVID-19 SARS-CoV-2 Antigen Kit is Approved by Malaysia MDA

Evaluation of the Goldsite SARS-CoV-2 Antigen Kit was succesfully completed. The device showed that it was able to detect the presence of SARS-CoV-2 antigen in the tested nasal samples with 96.7% sensitivity and 100% specificity.


This is a substantial proof that Goldsite's Self test Rapid Antigen Test Kit (ATK) keeps showing its excellent and stable performance.

Main Features of Goldsite SARS-CoV-2 Antigen Kit

  • EASY. No special equipment and expertise needed.

  • Accurate. Clinical performance of sensitivity and specificity: 100%, 97.17%

  • RAPID. Only 12 mins waiting time.

  • Nasal, nasopharyngeal and oropharyngeal swabs acceptable

  • Good correlation with RT-PCR detection.

  • Room temperature storage

Goldsite Diagnostics Inc., founded in 1999, is a leading Chinese diagnostics manufacturer specializing in in-vitro diagnostics devices and reagents.

Get in touch

    (+86)-755-26890807

        (+86)-755-26897973
   export@goldsite.com.cn

 

Copyright © 1999- 2023 Goldsite Diagnostics Inc., All rights reserved.   Sitemap